Global Celiac Drugs Market, By Type (Biological Drugs, Immunosuppresants, Corticosteroids, Others), Application (Classical Celiac Disease, Non- Classical Celiac Disease, Silent Celiac Disease), Route of Administration (Topical, Parenteral, Oral, Others), End-Users (Hospitals, Specialty Clinics, Home Healthcare, Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Patient Monitoring Device/System/Equipment Market was valued at USD 11.97 billion in 2023 and will reach USD 23.02 billion, with a CAGR of 8.52% by 2031